Bio-Techne Corp

US

TECHX

Health Care

62.8 ₽

Current price

Hold
62.8 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    81 / 240

  • Position in country

    5547 / 14179

  • Return on Assets, %

    8.6

    -2.7

  • Net income margin, %

    10

    -6.7

  • EBITDA margin, %

    28.2

    5.6

  • Debt to Equity, %

    22.7

    15.1

  • Intangible assets and goodwill, %

    56

    4.7

  • Revenue CAGR 3Y, %

    15.4

    12.8

  • Total Equity change 1Y, %

    7.4

    -2.4

  • Revenue Y, % chg

    2.2

    0

  • P/E

    48.1

    32.1

  • P/BV

    5.3

    2

  • P/S

    9.1

    4.1

  • EV/S

    9.4

    3.6

  • EV/EBITDA

    27.7

    7.8

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    19.8

    48.9

  • Forward P/E

    33.8

    25.5

  • Dividend Yield, %

    0.4

    0.8

  • Forward Dividend Yield, %

    0.4

    0.2

  • Expected dividend per share

    0.3

    0

  • Payout Ratio, %

    22.4

    10.1

  • Dividend Ex Date

    2024-02-09

Get an analytical review of this company

Competitors

Ranks

  • IQVIA Holdings Inc

    00%

  • West Pharmaceutical Services Inc

    00%

  • Bio-Techne Corp

    00%

  • Agilent Technologies Inc

    00%

  • Avantor Inc

    00%

  • Thermo Fisher Scientific Inc

    00%

  • Danaher Corp

    00%

  • Waters Corp

    00%

  • Mettler-Toledo International Inc

    00%

  • Illumina Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Life Sciences Tools & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    10489.4

  • Ticker

    TECH.O

  • ISIN

    US09073M1045

  • IPO date

    1989-02-09

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-07

  • Date fact. publication of reports

    2023-12-31

Company Description

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: